Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2019
Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trialAtul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, et al.JCO Global Oncology|July 11, 2025
Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North IndiaChitrakshi Nagpal, Mohit Kumar Divakar, Hemavathi Baskarane, et al.Journal of Immunology Research|March 11, 2026
Cytokine Signatures Outperform Immune Subsets in Machine Learning Models for Predicting Acute Graft-Versus-Host Disease at Neutrophil EngraftmentMohini Mendiratta, Praful Pandey, Shobhit Pandey, et al.Cancers|June 13, 2025
RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid LeukemiaHarsh Goel, Avanish Kumar Pandey, Rahul Kumar, et al.The Indian Journal of Medical Research|November 9, 2022
Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from IndiaAkash Kumar, Saphalta Baghmar, Prashant Mehta, et al.Iscience|April 20, 2026
Hypoxia-induced metabolic and apoptotic reprogramming enhances immunomodulation in Wharton's jelly mesenchymal stem cellsMohini Mendiratta, Meenakshi Mendiratta, Sujata Mohanty, et al.Stem Cell Research & Therapy|October 29, 2024
Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease modelMohini Mendiratta, Meenakshi Mendiratta, Shuvadeep Ganguly, et al.Clinical Lymphoma, Myeloma & Leukemia|June 13, 2025
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in IndiaSmeeta Gajendra, Tanima Dwivedi, Karthik Bommannan, et al.Pageof 9